These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 11525086

  • 1. [The thiazolidinedione derivates: a new class of oral blood glucose lowering agents].
    Jazet IM, Meinders AE.
    Ned Tijdschr Geneeskd; 2001 Aug 11; 145(32):1541-7. PubMed ID: 11525086
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
    Shibata T, Matsui K, Nagao K, Shinkai H, Yonemori F, Wakitani K.
    Eur J Pharmacol; 1999 Jan 08; 364(2-3):211-9. PubMed ID: 9932726
    [Abstract] [Full Text] [Related]

  • 3. Troglitazone and related compounds: therapeutic potential beyond diabetes.
    Fujiwara T, Horikoshi H.
    Life Sci; 2000 Oct 06; 67(20):2405-16. PubMed ID: 11065164
    [Abstract] [Full Text] [Related]

  • 4. [Thiazolidinediones--a new class of oral antidiabetic drugs].
    Jermendy G, Csermely P.
    Orv Hetil; 2001 Jul 22; 142(29):1547-54. PubMed ID: 11494746
    [Abstract] [Full Text] [Related]

  • 5. Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence.
    Diamant M, Heine RJ.
    Drugs; 2003 Jul 22; 63(13):1373-405. PubMed ID: 12825962
    [Abstract] [Full Text] [Related]

  • 6. [Thiazolidinediones: clinical data and perspectives].
    Blicklé JF.
    Diabetes Metab; 2001 Apr 22; 27(2 Pt 2):279-85. PubMed ID: 11452222
    [Abstract] [Full Text] [Related]

  • 7. Rosiglitazone.
    Balfour JA, Plosker GL.
    Drugs; 1999 Jun 22; 57(6):921-30; discussion 931-2. PubMed ID: 10400405
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of a thiazolidinedione compound as a new antidiabetic drug].
    Toyota T.
    Nihon Rinsho; 2001 Nov 22; 59(11):2211-8. PubMed ID: 11712410
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Promising new approaches.
    Reasner CA.
    Diabetes Obes Metab; 1999 May 22; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Insulin resistance and its treatment by thiazolidinediones.
    Lebovitz HE, Banerji MA.
    Recent Prog Horm Res; 2001 May 22; 56():265-94. PubMed ID: 11237217
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Rosiglitazone(BRL-49653)].
    Yonezawa N, Oka Y.
    Nihon Rinsho; 2001 Nov 22; 59(11):2195-9. PubMed ID: 11712407
    [Abstract] [Full Text] [Related]

  • 18. [Rosiglitazone (BRL-49653)].
    Kameda N, Okuya S, Oka Y.
    Nihon Rinsho; 2000 Feb 22; 58(2):401-4. PubMed ID: 10707565
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The rise and fall of troglitazone.
    Bailey CJ.
    Diabet Med; 2000 Jun 22; 17(6):414-5. PubMed ID: 10975209
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.